Viewing Study NCT03301805


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-01-09 @ 9:14 AM
Study NCT ID: NCT03301805
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-09
First Post: 2017-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer
Sponsor: Rgene Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module